Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Cresotab 40mg*


Contraindicated

Contraindicated
Cresotab 40mg* :
Type Medicine Non Marketed
Originator Crestor 40mg
Agent Mersaco
Distributor Mersaco
Laboratory Tabuk
Responsible Party Tabuk Pharmaceutical Manufacturing Company
Origin KSA
Manufacturer Tabuk Pharmaceutical Manufacturing Company
Manufacturing Type G
Origin KSA
ATC C10AA07

Your comment will appear shortly after approval

Cresotab 40mg* :

Revision Date : 01/03/2016


Effect Frequency
Abdominal pain Common
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Arthralgia (Pain joint) (Joint ache) Very rare
Asthenia Common
Cephalea Common
Constipation Common
Cough Not known
Depression Not known
Diarrhoea (Diarrhea) Not known
Dizziness Common
Dyspnoea (dyspnea) Not known
Eruption Uncommon
Gynecomastia (Gynaecomastia) Very rare
Haematuria (Hematuria) Very rare
Hepatitis Very rare
Hypersensitivity reactions Rare
Immune-mediated necrotising myopathy Not known
Insomnia Not known
Jaundice Very rare
Memory impairment Very rare
Myalgia Common
Myopathy Rare
Myositis Rare
Nausea Common
Neuropathy peripheral Not known
Nightmares Not known
Oedema Not known
Pancreatitis Rare
Polyneuropathy Very rare
Pruritus Uncommon
Rhabdomyolysis Rare
Sleep disorder (Sleep disturbance) Not known
Stevens-Johnson syndrome Not known
Tendon disorder Not known
Tendon rupture Not known
Thrombocytopenia (Thrombopenia) Rare
Transaminases increased Rare
Type 2 diabetes mellitus Common
Urticaria Uncommon

Different Units By MoH Code

Cresotab 40mg*  MoH 7863 :
Form Tablet, Film-Coated
Packaging Blisters
Package Size Box of 30
Strength 40mg
NSSF ✘
Quarantine ✘
Reg. Number 186189/13
Submission date 01/01/2013
Registration Year 2015
Archived Date 2019


Price Comparison

● Country: KSA
● Package Size: 30
● Public Price: 210.4 SAR ( 4,973,856.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 7,0133 SAR ( 165,480.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info